# National Cancer Center, Korea: Not applicable (device, behavioral) study in Advanced Solid Tumors, Metastatic Solid Tumors (2800 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | National Cancer Center, Korea |
| Sponsor type | Non-US government |
| Study | Master Protocol for Basket Clinical Trials of Targeted Therapies Based on Proteome and Whole Exome Sequencing Screening in Patients With Advanced Solid Tumors |
| NCT ID | NCT07891169 |
| Phase | Not applicable (device, behavioral) |
| Status | active not recruiting |
| Conditions | Advanced Solid Tumors; Metastatic Solid Tumors; Locally Advanced Solid Tumors; Recurrent Solid Tumors; Proteogenomic Screening and Molecular Signaling; Basket Clinical Trial Framework |
| Intervention types | drug |
| Target enrollment | 2800 |
| Site countries | South Korea |
| Posted | 2026-10-23 |
| Planned start | 2024-11-18 |
| Event | Newly registered study |
| Event date | 2026-10-23 |

## Why this score
- Posted in the last two weeks.
- 2800 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07891169). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.